Oxidative stress is a central etiologic factor in diabetes, cardiovascular disease, reperfusion injury, and various other pathologies. In vertebrates a major defense against oxidative and xenobiotic stress is orchestrated by the two Nrf bZIP transcription factors, which induce expression of a battery of Phase II detoxification enzymes. These enzymes synthesize glutathione and scavenge free radicals directly. This stress response system is also activated by chemoprotective antioxidants that are produced by many plants, and can inhibit chemical carcinogenesis in mice. We have determined that in C. elegans , this oxidative stress defense is mediated by the transcription factor SKN-1 (An and Blackwell (2003) Genes Dev., 17, 1882). SKN-1 is distantly related to Nrf proteins but binds DNA through a unique monomeric mechanism, indicating that this detoxification system has been conserved despite a dramatic divergence in DNA recognition. Previous work showed that in the embryo, maternally expressed SKN-1 initiates formation of the entire digestive system and other mesendodermal tissues. We have found that during postembryonic stages, zygotically expressed SKN-1 accumulates in intestinal nuclei in response to oxidative stress and directly regulates a key Phase II gene through constitutive and stress-inducible mechanisms in different tissues. In contrast, SKN-1 is constitutively nuclear and active in the ASI neurons.
skn-1 mutants are sensitive to oxidative stress, and age prematurely. We believe that the developmental function of SKN-1 arose from this ancient conserved stress response. We are now investigating how this detoxification response is regulated in the C. elegans intestine. The Matsumoto lab has shown that a
p38-like stress-activated kinase (PMK-1) phosphorylates SKN-1, and
p38 signaling is required for SKN-1 to accumulate in nuclei or activate target genes in response to oxidative stresses. We have found that the C. elegans glycogen synthase kinase-3 (GSK-3) alpha/beta ortholog
gsk-3 prevents constitutive SKN-1 activation. When
gsk-3 is inhibited by RNAi, SKN-1 is localized to intestinal nuclei without oxidative stress. A direct GSK-3 phosphorylation site and putative priming kinase site that we have identified are each required to prevent constitutive localization of SKN-1 to intestinal nuclei. The
p38 pathway regulates SKN-1 epistatically to GSK-3, indicating that it is required for SKN-1 function independently of mechanisms that overcome effects of GSK-3 on SKN-1. Our experiments have identified novel components of this conserved oxidative stress response, and have shown that oxidative stress resistance is modulated by a kinase (GSK-3) that has many key functions in metabolism, growth control, and differentiation. We believe that in the intestine SKN-1 integrates multiple redox and metabolic inputs. Mechanisms through which these and other signals may regulate SKN-1 are under investigation.